ZHAO Yanmei, ZHANG Jiankang, CAI Zhaobin, ZHUANG Rangxiao, PAN Jinming, LIU Shourong. Clinical Research Progress of Akt Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2017, 34(4): 625-630. DOI: 10.13748/j.cnki.issn1007-7693.2017.04.033
    Citation: ZHAO Yanmei, ZHANG Jiankang, CAI Zhaobin, ZHUANG Rangxiao, PAN Jinming, LIU Shourong. Clinical Research Progress of Akt Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2017, 34(4): 625-630. DOI: 10.13748/j.cnki.issn1007-7693.2017.04.033

    Clinical Research Progress of Akt Inhibitors

    • With various clinical trials being conducted of more than ten small Akt inhibitors in these years, the potential of Akt as a promising anti-cancer drug target has been validated. In this review, the structure and function of Akt as well as some promising small Akt inhibitors such as Perifosine, MK-2206 and GSK2110183 are going to be introduced. Additionally, the preclinical and clinical research will be illustrated in detail.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return